Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow

TORONTO, Ont. — The most valuable car ever to be offered in Prostate Cancer Canada’s annual Rock the Road Raffle is set to be given away at the 2019 Canadian International AutoShow.

Generously donated by the Trillium Automobile Dealers Association (TADA), one lucky person will be taking home a flashy red 2018 Acura NSX, valued at $235,000. Since 2013, the six previous Rock the Road Raffles have raised $1.8 million for research and support services funded by Prostate Cancer Canada.

“Rock the Road Raffle is an extremely important way to raise funds so we can make a difference in the lives of the one in seven Canadian men and their families facing a prostate cancer diagnosis,” says Peter Coleridge, President and CEO, Prostate Cancer Canada. “TADA has gone above and beyond with the highest sticker price yet for a raffle car. It will be exciting to see one lucky person drive away from the AutoShow in this incredible vehicle.”

Prostate cancer is the most common cancer affecting Canadian men, killing an estimated 4,100 each year.  Raffle funds help Prostate Cancer Canada continue making its contribution to the ongoing decline in the death rate from this disease.

“Rock the Road Raffle has become one of the most anticipated events at the Canadian International AutoShow,” says Larry Lantz, President of the 2019 Canadian International AutoShow. “Year in and out, TADA puts a stunning car on the block. With a total of 30,000 number of tickets available, the odds are favourable while letting all purchasers know they support one of the most vital causes in men’s health.”

Tickets for the 2019 Rock the Road Raffle are available until February 21, 2019, at, by calling 1-855-441-1267 and in person at the Canadian International AutoShow. The draw will take place at noon on February 22 at the AutoShow. Tickets cost $25 each or three for $60.

Raffled cars since 2013 have included a Camaro ZL1, Corvette Stingray 3LT, Mustang GT, Audi S5, Dodge Hellcat Challenger and a Porsche Carrera Cabriolet.

For AutoShow tickets and show information, please visit Stay connected with the Canadian International AutoShow on Instagram @cdnintlautoshow, Twitter@autoshowcanadaand Facebook /autoshowcanada.

About the Canadian International AutoShow

With more than 650,000 square feet of exhibits, displays and attractions at the Metro Toronto Convention Centre, the Canadian International AutoShow is not only the largest automotive expo in Canada, it is also the country’s largest consumer show — a leader in lifestyle, technology and all things automotive. It boasts more than 1,000 cars, trucks, SUVs, concept cars, exotics, classics, muscle cars, fully electric and autonomous vehicles each year.

About Prostate Cancer Canada

Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness. As one of the largest charitable investors in prostate cancer research in Canada, Prostate Cancer Canada is committed to continuous discovery in the areas of prevention, diagnosis, treatment, and support. Learn more at Prostate Cancer Canada is proud to have been named one of Canada’s top 3 health charities for efficiency and financial transparency in the Financial Post’s 2017 Charities of the Year list.

— 30 —

For more information, please contact:

Kalvin Reid
Senior Consultant
Mobile: 289-241-7936
Office: 905-346-1233
Arden Bagni
Manager, Communications
Prostate Cancer Canada
Office: 416-441-2131 ext 264
Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive